These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 22837067)
1. Serum apoptosis markers in HIV-infected patients with human herpesvirus type 8 and herpes simplex virus type 2 co-infection. Dakovic Rode O; Markotic A; Kujundzic Tiljak M; Zidovec Lepej S; Begovac J Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3303-8. PubMed ID: 22837067 [TBL] [Abstract][Full Text] [Related]
2. Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus. Lapinski TW; Jaroszewicz J; Wiercinska-Drapalo A Viral Immunol; 2006; 19(3):570-5. PubMed ID: 16987075 [TBL] [Abstract][Full Text] [Related]
3. Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients. Masiá M; Robledano C; Ortiz de la Tabla V; Antequera P; Lumbreras B; Hernández I; Gutiérrez F PLoS One; 2014; 9(8):e105442. PubMed ID: 25133669 [TBL] [Abstract][Full Text] [Related]
4. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Harris J; Hoi AY; Mackay F; Morand EF Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32546562 [TBL] [Abstract][Full Text] [Related]
5. Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy. Guzmán-Fulgencio M; Berenguer J; García-Álvarez M; Micheloud D; C López J; Cosín J; Fernández de Castro I; Catalán P; Miralles P; Resino S Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1213-21. PubMed ID: 21442358 [TBL] [Abstract][Full Text] [Related]
6. Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. Volpi A; Sarmati L; Suligoi B; Montano M; Rezza G; Andreoni M J Med Virol; 2004 Nov; 74(3):467-72. PubMed ID: 15368514 [TBL] [Abstract][Full Text] [Related]
7. Correlation of loss of CD4 T cells with plasma levels of both soluble form Fas (CD95) Fas ligand (FasL) in HIV-infected infants. Hosaka N; Oyaizu N; Than S; Pahwa S Clin Immunol; 2000 Apr; 95(1 Pt 1):20-5. PubMed ID: 10794428 [TBL] [Abstract][Full Text] [Related]
8. HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution. Yap SH; Abdullah NK; McStea M; Takayama K; Chong ML; Crisci E; Larsson M; Azwa I; Kamarulzaman A; Leong KH; Woo YL; Rajasuriar R PLoS One; 2017; 12(10):e0186000. PubMed ID: 29016635 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis. Musiał K; Zwolińska D Apoptosis; 2011 Jul; 16(7):653-9. PubMed ID: 21516345 [TBL] [Abstract][Full Text] [Related]
10. The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer. Yildiz R; Benekli M; Buyukberber S; Kaya AO; Ozturk B; Yaman E; Berk V; Coskun U; Yamac D; Sancak B; Uner A J Cancer Res Clin Oncol; 2010 Oct; 136(10):1471-6. PubMed ID: 20155284 [TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of herpes simplex virus type 2 in adult HIV-infected patients and blood donors in Croatia. Rode OD; Lepej SZ; Begovac J Coll Antropol; 2008 Sep; 32(3):693-5. PubMed ID: 18982739 [TBL] [Abstract][Full Text] [Related]
12. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma. Mouawad R; Khayat D; Soubrane C Melanoma Res; 2000 Oct; 10(5):461-7. PubMed ID: 11095407 [TBL] [Abstract][Full Text] [Related]
13. Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma. Boroumand-Noughabi S; Sima HR; Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Hosseinnezhad H; Moaven O; Rajabi-Mashhadi MT; Azarian AA; Mashhadinejad M; Tavakkol-Afshari J BMC Cancer; 2010 Jun; 10():275. PubMed ID: 20534173 [TBL] [Abstract][Full Text] [Related]
14. Influence of levothyroxine treatment on serum levels of soluble Fas (CD95) and Fas Ligand (CD95L) in chronic autoimmune hypothyroidism. Nabipour I; Kalantarhormozi M; Assadi M; Jafari SM; Gharibi M; Ahmadi E; Sanjdideh Z Endocrine; 2010 Dec; 38(3):406-11. PubMed ID: 21042884 [TBL] [Abstract][Full Text] [Related]
15. Soluble Fas/FasLare elevated in the serum and cerebrospinal fluid of patients with neurocysticercosis. Chen X; Yu X; Wang Y; Zhu J; Gu J Parasitol Res; 2017 Nov; 116(11):3027-3036. PubMed ID: 28965226 [TBL] [Abstract][Full Text] [Related]
16. [Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B]. Jun EJ; Han JY; Sun HS Korean J Hepatol; 2006 Dec; 12(4):507-14. PubMed ID: 17237628 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of soluble concentration Fas and Fas ligand in maternal and cord blood 3rd trimester of pregnancy. Karowicz-Bilińska A; Kowalska-Koprek U; Estemberg D; Sikora-Szubert A Ginekol Pol; 2018; 89(3):142-146. PubMed ID: 29664549 [TBL] [Abstract][Full Text] [Related]
18. A Fas gene polymorphism influences herpes simplex virus type 2 infection in South African women. Chatterjee K; Dandara C; Gyllensten U; van der Merwe L; Galal U; Hoffman M; Williamson AL J Med Virol; 2010 Dec; 82(12):2082-6. PubMed ID: 20981796 [TBL] [Abstract][Full Text] [Related]
19. Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons. Hosaka N; Oyaizu N; Kaplan MH; Yagita H; Pahwa S J Infect Dis; 1998 Oct; 178(4):1030-9. PubMed ID: 9806031 [TBL] [Abstract][Full Text] [Related]
20. Human herpes virus-8 infections among subjects with human immunodeficiency virus infection and normal healthy individuals in India. Sachithanandham J; Kannangai R; Abraham AM; Fletcher GJ; Abraham OC; Daniel D; Pulimood SA Intervirology; 2013; 56(4):253-7. PubMed ID: 23774948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]